Molecular characterisation of NPM1 and FLT3-ITD mutations in a central South African adult de novo acute myeloid leukaemia cohort
Background: Recognition of molecular abnormalities in acute myeloid leukaemia (AML) has improved our understanding of its biology. NPM1 and FLT3-ITD mutations are recurrent in AML and clinically significant. NPM1 mutations are associated with a favourable prognosis, while FLT3-ITD mutations are an i...
Saved in:
Main Authors: | Jean F. Kloppers (Author), André de Kock (Author), Johané Cronjé (Author), Anne-Cecilia van Marle (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NPM1 and FLT3 mutations in acute myeloid leukemia with normal karyotype: Indian perspective
by: Sudha Sazawal, et al.
Published: (2017) -
Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML
by: Franziska Schmidt, et al.
Published: (2022) -
Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia
by: Jiewen Sun, et al.
Published: (2020) -
The Myc/Max/Mxd Network Is a Target of Mutated Flt3 Signaling in Hematopoietic Stem Cells in Flt3-ITD-Induced Myeloproliferative Disease
by: Farhan Basit, et al.
Published: (2018) -
Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways
by: Genhong Li, et al.
Published: (2023)